Instil Bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TIL research report →
About the company
Instil Bio, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on devising novel therapeutic options for individuals battling cancer. A cornerstone of their research involves the advancement of autologous tumor-infiltrating lymphocyte (TIL) cell therapies.
- CEO
- Bronson Crouch
- IPO
- 2021
- Employees
- 14
- HQ
- Dallas, TX, US
Price Chart
- Market Cap
- $52.42M
- P/E
- -1.09
- P/S
- 0.00
- P/B
- 0.47
- EV/EBITDA
- -3.19
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -39.76%
- ROIC
- -27.59%
- Revenue
- $0 · 0.00%
- Net Income
- $-71,372,000 · 3.73%
- EPS
- $-10.70 · 6.06%
- Op Income
- $-52,907,000
- FCF YoY
- 44.26%
- 52W High
- $33.83
- 52W Low
- $5.67
- 50D MA
- $7.94
- 200D MA
- $10.84
- Beta
- 1.91
- Avg Volume
- 25.22K
Get TickerSpark's AI analysis on TIL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | McGaughy R Kent Jr | other | 6,500 |
| Jun 11, 26 | Matcham George | other | 6,500 |
| Jun 11, 26 | Gibson Neil W | other | 0 |
| Jun 11, 26 | Binder Gwendolyn | other | 6,500 |
| Sep 10, 25 | Laumas Sandeep | other | 13,000 |
| Sep 10, 25 | Laumas Sandeep | other | 13,000 |
| Sep 10, 25 | Laumas Sandeep | other | 17,000 |
| Sep 10, 25 | Laumas Sandeep | other | 17,000 |
| Sep 10, 25 | Laumas Sandeep | sell | 17,539 |
| Sep 10, 25 | Laumas Sandeep | sell | 12,461 |
Our TIL coverage
Recent articles, reports, and earnings notes.
No research on TIL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TIL report →Similar companies
Peers in the same neighborhood.